Volume 27, Issue 2 pp. 101-104
Therapeutic Hotline

Pitted keratolysis, erythromycin, and hyperhidrosis

Guglielmo Pranteda

Corresponding Author

Guglielmo Pranteda

Dermatology Unit, NESMOS Department, Faculty of Medicine and Psychology “Sapienza” University Rome “S. Andrea Hospital,”, Rome, Italy

Address correspondence and reprint requests to: Guglielmo Pranteda, MD, Professor, Via di Grottarossa 1035, 00189 Rome, Italy, or email: [email protected].Search for more papers by this author
Marta Carlesimo

Marta Carlesimo

Dermatology Unit, NESMOS Department, Faculty of Medicine and Psychology “Sapienza” University Rome “S. Andrea Hospital,”, Rome, Italy

Search for more papers by this author
Giulia Pranteda

Giulia Pranteda

Dermatology Unit, Faculty of Medicine, Umberto I Hospital, Sapienza University, Rome, Italy

Search for more papers by this author
Claudia Abruzzese

Claudia Abruzzese

Dermatology Unit, NESMOS Department, Faculty of Medicine and Psychology “Sapienza” University Rome “S. Andrea Hospital,”, Rome, Italy

Search for more papers by this author
Miriam Grimaldi

Miriam Grimaldi

Plastic Surgery Unit, Madonna delle Grazie Hospital, Matera, Italy

Search for more papers by this author
Sabrina De Micco

Sabrina De Micco

Dermatology Unit, NESMOS Department, Faculty of Medicine and Psychology “Sapienza” University Rome “S. Andrea Hospital,”, Rome, Italy

Search for more papers by this author
Marta Muscianese

Marta Muscianese

Dermatology Unit, NESMOS Department, Faculty of Medicine and Psychology “Sapienza” University Rome “S. Andrea Hospital,”, Rome, Italy

Search for more papers by this author
Ugo Bottoni

Ugo Bottoni

Department of Health Science, University Magna Graecia, Catanzaro, Italy

Search for more papers by this author
First published: 24 May 2013
Citations: 22

Abstract

Pitted keratolysis (PK) is a plantar skin disorder mainly caused by coryneform bacteria. A common treatment consists of the topical use of erythromycin. Hyperhidrosis is considered a predisposing factor for bacterial proliferation and, consequently, for the onset of PK. The aim of this study was to evaluate the relationship between PK erythromycin and hyperhidrosis. All patients with PK seen in Sant'Andrea Hospital, between January 2009 and December 2011, were collected. PK was clinically and microscopically diagnosed. All patients underwent only topical treatment with erythromycin 3% gel twice daily. At the beginning of the study and after 5 and 10 days of treatment, a clinical evaluation and a gravimetric measurement of plantar sweating were assessed. A total of 97 patients were diagnosed as PK and were included in the study. Gravimetric measurements showed that in 94 of 97 examined patients (96.90%) at the time of the diagnosis, there was a bilateral excessive sweating occurring specifically in the areas affected by PK. After 10 days of antibiotic therapy, hyperhidrosis regressed together with the clinical manifestations. According to these data, we hypothesize that hyperhidrosis is due to an eccrine sweat gland hyperfunction, probably secondary to bacterial infection.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.